Custom CGM patches from Dexcom for World Diabetes Day
Dexcom, a global leader in real-time continuous glucose monitoring, is inviting members of the diabetes community to express their unique journey with diabetes by creating
Dexcom, a global leader in real-time continuous glucose monitoring, is inviting members of the diabetes community to express their unique journey with diabetes by creating
DC4U, an immunology company developing innovative treatments for auto-immune diseases and allergies, has been awarded a €1.7m Eurostars (SiaDM) grant, together with a Leiden University
An international drive to highlight the importance of the prevention and adequate management of diabetes has been proposed by a team of the world’s leading
A leading charity partnership is urging more people to check their risk of Type 2 diabetes through a free online tool as new figures reveal
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new drug capsule with a robotic cap for improved drug delivery. Because large-protein drugs
Use of an older class of Type 2 diabetes drugs called glitazones (also known as thiazolidinediones or TZDs) is linked to a 22% reduced risk
The National Institute for Health and Care Research (NIHR) has announced a £26 million investment in an NIHR Leicester Biomedical Research Centre (BRC) – a
Eli Lilly plans to introduce a personalized diabetes management platform that integrates with technologies, including Dexcom’s continuous glucose monitoring (CGM) systems. The platform, branded Tempo,
A team of University of British Columbia (UBC) researchers has discovered that insulin from the oral insulin tablets they are developing is absorbed by rats
People from ethnic minority and marginalised community groups are being offered advice on health issues that disproportionately affect them. The Bristol Community Health Day on